10.45Open10.45Pre Close0 Volume0 Open Interest17.00Strike Price0.00Turnover124.94%IV39.74%PremiumJan 17, 2025Expiry Date6.13Intrinsic Value100Multiplier23DDays to Expiry4.32Extrinsic Value100Contract SizeAmericanOptions Type-0.8966Delta0.0554Gamma1.74Leverage Ratio-0.0117Theta-0.0068Rho-1.56Eff Leverage0.0049Vega
Anavex Life Sciences Stock Discussion
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Anavex Life Sciences (AVXL.US)$ , $Limoneira (LMNR.US)$ and $Venu Holding (VENU.US)$ are releasing their earnings. How will the market react to the companies' results? Let's keep our eyes peeled and see who will shine b...
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
No comment yet